The hemorheological effects of raloxifene in postmenopausal women with osteoporosis. Results of a 3-year placebo-controlled clinical trial

Clinical Hemorheology and Microcirculation

Volumn 26, Issue 4, 2002, Pages 249-255

  Shand, Brett I ^a   Gilchrist, Nigel ^a   Blackwell, Terri ^a   March, Rachel ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Clinical trial; Hemorheology; Post menopause; Raloxifene; SERM; Venous thromboembolism

Indexed keywords

FIBRINOGEN; RALOXIFENE;

AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD ANALYSIS; BLOOD RHEOLOGY; BLOOD SAMPLING; BLOOD VISCOSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DRUG EFFECT; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMATOCRIT; HEMODYNAMIC PARAMETERS; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PLASMA VISCOSITY; POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; SHEAR RATE; STATISTICAL SIGNIFICANCE; THROMBOEMBOLISM; TIME; TREATMENT OUTCOME;

AGED; BLOOD VISCOSITY; ESTROGEN ANTAGONISTS; FEMALE; FIBRINOGEN; HEMORHEOLOGY; HUMANS; MIDDLE AGED; OSTEOPOROSIS; PLACEBOS; POSTMENOPAUSE; PROSPECTIVE STUDIES; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; STRESS, MECHANICAL; TREATMENT OUTCOME;

EID: 0036037592     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in post-menopausal women
2. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. Results from a 3-year randomized clinical trial
3. A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal women
4. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
5. Effects of oestrogens and selective oestrogen receptor modulators on serum lipoproteins and vascular function
6. Selective estrogen receptor modulators: Different actions on vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells
7. Raloxifene: A selective estrogen receptor modulator
8. Raloxifene: A review of its use in osteoporosis
9. Selective oestrogen receptor modulators
10. Pathogenesis of arterial thrombosis
11. Rheological influences on thrombosis
12. Guidelines for measurement of blood viscosity and erythrocyte deformability
13. A simple method of estimating whole blood viscosity at standardized hematocrit
14. Recommendation for a selected method for the measurement of plasma viscosity
15. An evaluation of the heat precipitation method for plasma fibrinogen estimation
16. Hemorheological consequences of estrogen and progesterone therapy
17. Rheological studies in obstetrics and gynaecology
18. The place of red cell filterability in the microcirculation
19. Viscosity, vascular disease and the elderly